We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Kromek Group Plc | LSE:KMK | London | Ordinary Share | GB00BD7V5D43 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.05 | -0.67% | 7.45 | 7.30 | 7.60 | 7.55 | 7.40 | 7.55 | 579,634 | 09:29:46 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Miscellaneous Metal Ores,nec | 17.31M | -6.1M | -0.0102 | -7.30 | 44.72M |
Date | Subject | Author | Discuss |
---|---|---|---|
16/7/2021 16:36 | Great posts Mick. I think it's possible our Covid detector could see more demand then any of us ever imagined(if proven to work well). Any chance you can copy your posts to lse also? Not everyone reads advfn. | ark87 | |
16/7/2021 16:17 | Thanks Mick, I know a little about RNA/DNA sequencing, investment wise, through a long holding I had in SMT. Illumina, is one of its largest positions and they provided Moderna with the genetic sequencing for Covid 19, within 24hrs of receiving it, and are considered the benchmark. Fascinating to know what Kromek are using and how massive companies like Illumina would view them.Illumina and Moderna are now of course mega companies trading at billions of dollars. No direct comparison of course but in a relatable market. | dexter1612 | |
16/7/2021 15:52 | The very first bit of digging I did last November was to figure out which unique UK RNA/DNA sequencing platform Kromek are using...that's the main reason I invested here as its vastly superior to any other platforms which are clumbersome lab based tech. It's never talked about here so I don't bother mentioning it anymore, plus it's Commercially sensitive hence Kromek never name them. All any other competitors will be hard pushed to match it. No other platforms to my knowledge are near in Cost -first, Realtime -2nd Accuracy -3rd Size -4th If they try to use the same UK platform they're 2 years + behind Kromek and maybe they wouldn't deal with them anyway......who knows | 33mick | |
16/7/2021 15:39 | If the 'IP' rights and patents are locked in, it is probably a race to be first market mover for these detection machines. The new 'buy' UK and support UK innovation should definitely help. Already being chosen as a supplier to DARPA suggests to me they have met many challenging benchmarks that most would fail, to supply the US military or be on the cusp of.If this was on the Dow or Nasdaq it would be worth a fortune. | dexter1612 | |
16/7/2021 15:27 | It tells me that some small American company will come along and get there before kmk. Only because kmk are too slow at getting there inventions to market. | b00mb0y | |
16/7/2021 15:20 | Cheers Dexter, I started making a list of JUST the Bio related news that we should /could/ might be hearing from Kromek which will probably have a positive effect on the share price here, and generate ongoing media interest. I had to get a bigger sheet of paper.. - News of 3rd party 'NHS lab' 'bio unit performance / sensitivity / Covid detection results. - Feedback from ongoing various UK Gov bodies re- Bio accreditation/valida - Futher trails announced (UK) - First US DARPA field trails / Prototype being produced for such - Kromek's web site update with new Bio unit product page. Official product range name etc info for potential customers to show interest. - Technical Press coverage in Science/Physics/Engi mags /periodicals - Other Analysis/Broker coverage.. - News about Bio manufacturing partnerships progress. Licence deals. - More prototypes being commissioned. (2 at present ?) - Interest from any Euro governments/Bodies - UK military interest /trails - Portland Down etc - Request s for trails by say - Cunnards or Cruiseline industry or any lead or launch customer news. - News about the DARPA vehicle mounted prototypes progress. that's just of the top of my head. There's probably a lot more.... | 33mick | |
16/7/2021 15:05 | For someone who just invested here having done some DD, thats an really informative post Mick, thanks. | dexter1612 | |
16/7/2021 12:47 | AQC888 in Nov last year DARPA and the US Defense Department put out a solicitation to all US tech companies to attempt.....Again... to develop a 'lab in a Box' fully automatic multi Patho/Virus/Bacteria Airborne system. Under the SenSARS project, I've read since then that some companies that meet certain very strict requirements were elegble to be awarded 500k US grants with another 500k on milestones being meet. This against Kromek's is it 13 million now? They are very keen to get this technology up and running and the tech hasn't been there up to recently to achieve their goals. So any Bio Covid virus other detection units that I'm sure we will read about in the future have to be 'lab in a box' Gold standard PCR+ they already use/have filter collect- send to lab set ups now. Kromek are miles ahead in their development and have met all DARPAS milestones so far....the others if they do appear are at early prof of concept stage I would imagine. So its probably prudent for any serious analyst to assume Kromek could have competition in a couple of years? But the 20% share of the market for Bio units and the 500mil dollar (Paul hill ) global market are just estimates and could be much higher. If you read any of the Biowatch US news they talk of multi year contracts of multi billion dollar sizes to role out this bio protection across US cites. Developments in Gene sequencing is not standing still...the UK tech that Kromek are using(my assumption) for example has been vastly improved performance / sensitivity & time wise since the start of Kromek's project. As you might have noticed the detection times mentioned by Kromek are now down to 30 mins or less. There appears to be many overlapping US military/gov/securit 'The SenSARS project aims to identify SARS-CoV-2 signatures suitable for rapid indoor air monitoring and develop a TRL-4 prototype sensor. ARLINGTON, Va. – U.S. military researchers are asking industry to develop technologies for sensors able to detect low concentrations if airborne viruses in room-size spaces within seconds to minutes to help detect the presence of pathogens like the COVID-19 coronavirus and prevent its spread. | 33mick | |
16/7/2021 12:23 | QuePassa - Are you implying KMK's Covid detector could be outright fraud a la Theranos? What are you trying to say here? edit: not surprised you deleted your post you utter muppet | ark87 | |
16/7/2021 09:34 | There isn’t a comparable detector out there.... | aqc888 | |
16/7/2021 09:33 | Analyst Peel Hunt estimates Kromek could gain a 20% market share of the annual market for the detector. (£25m annual profit). Who’s selling the remaining 80%???? | aqc888 | |
16/7/2021 09:18 | I doubt companies like this would think twice about ordering a detector per floor to avoid wearing face masks... | aqc888 | |
15/7/2021 11:00 | Hi - what are your main assumptions in your projection of 70% share price rise ? I see much greater potential but haven’t done a detailed forecast at this stage ? Thanks | strategicinvestor2 | |
15/7/2021 10:49 | Feeble attempt to deramp a stock up 10%. The price and volume shows this is now in play.I can see this up 70% in six months | ch1ck | |
15/7/2021 10:17 | AQC888 and 33mick - good posts from both, appreciate it. The presentation really helped me to see the whole company and the exciting potential in all of their areas. For the timelines, I was like "yep, that's what I thought". For me, Arnab came across as a bit more street wise too, in terms of not promising the moon tomorrow. They're dealing with many high level government agencies. He mentioned there are no standards for air monitoring of COVID. We're emerging from this pandemic and... anyway, suffice to say, I'm a confident holder now. DM | dougmachin | |
15/7/2021 09:41 | The ventilators are a perfect example of managements inability to communicate and manage investors expectations. I’m aware that at the start of the pandemic everybody including governments thought ventilators were the solution to people suffering with covid. However, as far as I’m aware the medical guidance changed and people suffering were given oxygen. Ventilators were only given to people in intensive care. There are not that many intensive care nurses and beds to go around. So having ventilators without the accompanying nurses was no use. So this was not a fault of Kromek. What is categorically the fault of management is not updating shareholders with this very reasonable explanation of what happened. The result of this is a very angry Que Passa who now disbelieves all the other things the management say. Another example of the failure of Kromeks management. If you can see through all this inept management. Then I think there’s an interesting company. A company in which a very experienced Simon Thompson has clearly identified as having huge value and upside. The problem is new investors have is that there is a huge queue of old fed up investors waiting to exit and keeping the share price suppressed | aqc888 | |
15/7/2021 09:22 | I think a lot of investors will be displeased about the ventilators which were announced to great fanfare in April 2020. Only yesterday, did we squeeze out of Kromek an answer as to how many had been made by them - which, according to dougmachin- was ZERO. Kromek must have known about that for a long time but never had the courtesy to update the market. Goes to the heart of credibility. ALL IMO. DYOR. QP | quepassa | |
15/7/2021 09:11 | Huge amount of selling going on. Not quite sure how the share price is holding up so well. Clearly a lot of investors fed up with management playing games with expectations constantly. | aqc888 | |
15/7/2021 09:05 | I’ve also read the same over on lse, aqc888. 👍 | b00mb0y | |
15/7/2021 08:44 | Bit of a disappointing start to the day. When the print edition comes out on the weekend and people get a chance to read it over the weekend I’d expect to see it go up a bit more. Surprised not to see it hit 20p yet. I think there are a lot of frustrated holders who have been waiting to get rid of Kromek who are taking the chance to get out now, right at the time things are looking the most hopeful. You can see one long term apparent largish holder on the lse Kromek chat who’s exiting, with 33mick of course abusing him over his questioning of Kromeks managements competence. | aqc888 | |
15/7/2021 08:39 | Thanks for the write up Doug. This looks like it may be getting some traction now. | robsy2 | |
15/7/2021 08:36 | Yes a few impatient holders sell ahead of the value coming out. People are beginning to understand the variety of world beating tech here and next few months likely to be very interesting. | strategicinvestor2 | |
15/7/2021 08:17 | Excited by the move, then saw it was just a simon thompson ramp. As you were :) | wigwammer |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions